Exosomes for intramyocardial intercellular communication

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Cervio, Elisabetta ^a,b   Barile, Lucio ^a,b   Moccetti, Tiziano ^a,b   Vassalli, Giuseppe ^a,b,c  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b Swiss Institute for Regenerative Medicine   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; MICRORNA; MICRORNA 132; MICRORNA 133; MICRORNA 146; MICRORNA 192; MICRORNA 210; MICRORNA 328; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; B LYMPHOCYTE; BONE MARROW CELL; CARDIAC STEM CELL; CELL COMMUNICATION; DENDRITIC CELL; ENDOTHELIUM CELL; EXOSOME; GENE EXPRESSION REGULATION; HEART FAILURE; HEART FIBROBLAST; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; INTERNALIZATION; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; MACROPHAGE; MESENCHYMAL STEM CELL; MULTIVESICULAR BODY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE CELL;

EID: 84930636929     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/482171     Document Type: Review

References (93)

1. P. Anversa, G. Olivetti, M. Melissari, and A. V. Loud, "Stere-ological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat," Journal of Molecular and Cellular Cardiology, vol. 12, no. 8, pp. 781-795, 1980.
2. M. A. Lafamme and C. E. Murry, "Heart regeneration," Nature, vol. 473, no. 7347, pp. 326-335, 2011.
3. L. Barile, E. Messina, A. Giacomello, and E. Marbán, "Endogenous cardiac stem cells," Progress in Cardiovascular Diseases, vol. 50, no. 1, pp. 31-48, 2007.
4. C. Téry, "Exosomes: secreted vesicles and intercellular communications," F1000 Biology Reports, vol. 3, article 15, 2011.
5. P. J. Quesenberry, L. R. Goldberg, J. M. Aliotta et al., "Cellular phenotype and extracellular vesicles: basic and clinical considerations," Stem Cells and Development, vol. 23, no. 13, pp. 1429-1436, 2014.
6. J. P. G. Sluijter, V. Verhage, J. C. Deddens, F. van den Akker, and P. A. Doevendans, "Microvesicles and exosomes for intracardiac communication," Cardiovascular Research, vol. 102, no. 2, pp. 302-311, 2014.
7. A. Khalyfa and D. Gozal, "Exosomal miRNAs as potential bio-markers of cardiovascular risk in children," Acta Veterinaria Scandinavica, vol. 12, article 162, 2014.
8. M. Simons and G. Raposo, "Exosomes-vesicular carriers for intercellular communication," Current Opinion in Cell Biology, vol. 21, no. 4, pp. 575-581, 2009.
9. K. Denzer, M. J. Kleijmeer, H. F. G. Heijnen, W. Stoorvogel, and H. J. Geuze, "Exosome: from internal vesicle of the multivesicular body to intercellular signaling device," Journal of Cell Science, vol. 113, no. 19, pp. 3365-3374, 2000.
10. T. Tian, Y. Wang, H. Wang, Z. Zhu, and Z. Xiao, "Visualizing of the cellular uptake and intracellular trafcking of exosomes by live-cell microscopy," Journal of Cellular Biochemistry, vol. 111, no. 2, pp. 488-496, 2010.
11. G. Camussi, M. C. Deregibus, S. Bruno, C. Grange, V. Fon-sato, and C. Tetta, "Exosome/microvesicle-mediated epigenetic reprogramming of cells," American Journal of Cancer Research, vol. 1, pp. 98-110, 2011.
12. A. Zernecke, K. Bidzhekov, H. Noels et al., "Delivery of microRNA-126 by apoptotic bodies induces CXCL12-depend-ent vascular protection," Science Signaling, vol. 2, no. 100, p. ra81, 2009.
13. R. M. Johnstone, "Revisiting the road to the discovery of exo-somes," Blood Cells, Molecules, and Diseases, vol. 34, no. 3, pp. 214-219, 2005.
14. S. Mathivanan, H. Ji, and R. J. Simpson, "Exosomes: extracellular organelles important in intercellular communication," Journal of Proteomics, vol. 73, no. 10, pp. 1907-1920, 2010.
15. A. Waldenström and G. Ronquist, "Role of exosomes in myo-cardial remodeling," Circulation Research, vol. 114, no. 2, pp. 315-324, 2014.
16. S. Sahoo and D. W. Losordo, "Exosomes and cardiac repair afer myocardial infarction," Circulation Research, vol. 114, no. 2, pp. 333-344, 2014.
17. A. Clayton, "Cancer cells use exosomes as tools to manipulate immunity and the microenvironment," OncoImmunology, vol. 1, no. 1, pp. 78-80, 2012.
18. L. M. Epple, S. G. Grifths, A. M. Dechkovskaia et al., "Medul-loblastoma exosome proteomics yield functional roles for extracellular vesicles," PLoS ONE, vol. 7, no. 7, Article ID e42064, 2012.
19. D. D. Taylor and C. Gercel-Taylor, "Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments," Seminars in Immunopathology, vol. 33, no. 5, pp. 441-454, 2011.
20. A. M. Marleau, C.-S. Chen, J. A. Joyce, and R. H. Tullis, "Exo-some removal as a therapeutic adjuvant in cancer," Journal of Translational Medicine, vol. 10, no. 1, article 134, 2012.
21. D. G. Meckes Jr. and N. Raab-Traub, "Microvesicles and viral infection," Journal of Virology, vol. 85, no. 24, pp. 12844-12854, 2011.
22. E. Hirsch, D. Hilfker-Kleiner, J.-L. Balligand et al., "Interaction of the heart and its close and distant neighbours: report of the Meeting of the ESC Working Groups Myocardial Function and Cellular Biology," Cardiovascular Research, vol. 99, no. 4, pp. 595-599, 2013.
23. L. Lugini, S. Cecchetti, V. Huber et al., "Immune surveillance properties of human NK cell-derived exosomes," The Journal of Immunology, vol. 189, no. 6, pp. 2833-2842, 2012.
24. H. Zhu and G. C. Fan, "Extracellular/circulating microRNAs and their potential role in cardiovascular disease," American Journal of Cardiovascular Disease, vol. 1, no. 2, pp. 138-149, 2011.
25. A. Eulalio, M. Mano, M. D. Ferro et al., "Functional screening identifes miRNAs inducing cardiac regeneration," Nature, vol. 492, no. 7429, pp. 376-381, 2012.
26. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells," Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
27. A. Montecalvo, A. T. Larregina, W. J. Shufesky et al., "Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes," Blood, vol. 119, no. 3, pp. 756-766, 2012.
28. M. Mittelbrunn and F. Sánchez-Madrid, "Intercellular communication: diverse structures for exchange of genetic information," Nature Reviews Molecular Cell Biology, vol. 13, no. 5, pp. 328-335, 2012.
29. M. Colombo, G. Raposo, and C. Téry, "Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles," Annual Review of Cell and Developmental Biology, vol. 30, no. 1, pp. 255-289, 2014.
30. M. Colombo, C. Moita, G. van Niel et al., "Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles," Journal of Cell Science, vol. 126, part 24, pp. 5553-5565, 2013.
31. R. J. Simpson, H. Kalra, and S. Mathivanan, "ExoCarta as a resource for exosomal research," Journal of Extracellular Vesicles, vol. 1, Article ID 18374, 2012.
32. S. Gupta and A. A. Knowlton, "HSP60 trafcking in adult cardiac myocytes: role of the exosomal pathway," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 6, pp. H3052-H3056, 2007.
33. Z. A. Malik, K. S. Kott, A. J. Poe et al., "Cardiac myocyte exo-somes: Stability, HSP60, and proteomics," American Journal of Physiology-Heart and Circulatory Physiology, vol. 304, no. 7, pp. H954-H965, 2013.
34. R. Kakkar and R. T. Lee, "Intramyocardial fbroblast myocyte communication," Circulation Research, vol. 106, no. 1, pp. 47-57, 2010.
35. A. Waldenström, N. Gennebäck, U. Hellman, and G. Ronquist, "Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells," PLoS ONE, vol. 7, no. 4, Article ID e34653, 2012.
36. N. Gennebäck, U. Hellman, L. Malm et al., "Growth factor stimulation of cardiomyocytes induces changes in the transcrip-tional contents of secreted exosomes," Journal of Extracellular Vesicles, vol. 2, 2013.
37. X. Yu, L. Deng, D. Wang et al., "Mechanism of TNF-α auto-crine efects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1α, presented by exosomes," Journal of Molecular and Cellular Cardiology, vol. 53, no. 6, pp. 848-857, 2012.
38. X. Zhang, X. Wang, H. Zhu et al., "Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2," PLoS ONE, vol. 7, no. 3, Article ID e32765, 2012.
39. X. Wang, W. Huang, G. Liu et al., "Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells," Journal of Molecular and Cellular Cardiology, vol. 74, pp. 139-150, 2014.
40. O. G. de Jong, M. C. Verhaar, Y. Chen et al., "Cellular stress conditions are refected in the protein and RNA content of endo-thelial cell-derived exosomes," Journal of Extracellular Vesicles, vol. 1, 2012.
41. B. W. M. van Balkom, O. G. de Jong, M. Smits et al., "Endothe-lial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells.," Blood, vol. 121, supplement 1, pp. 3997-4006, 2013.
42. E. Hergenreider, S. Heydt, K. Tréguer et al., "Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs," Nature Cell Biology, vol. 14, no. 3, pp. 249-256, 2012.
43. S. Ong, W. H. Lee, M. Huang et al., "Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer," Circulation, vol. 130, pp. S60-S69, 2014.
44. J. Halkein, S. P. Tabruyn, M. Ricke-Hoch et al., "MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy," The Journal of Clinical Investigation, vol. 123, no. 5, pp. 2143-2154, 2013.
45. J. Song, X. Chen, M. Wang, Y. Xing, Z. Zheng, and S. Hu, "Cardiac endothelial cell-derived exosomes induce specifc regulatory B cells," Scientifc Reports, vol. 4, article 7583, 2014.
46. D. M. Pedrotty, R. Y. Klinger, R. D. Kirkton, and N. Bursac, "Cardiac fbroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes," Cardiovascular Research, vol. 83, no. 4, pp. 688-697, 2009.
47. K. Nakazato, W. Naganuma, K. Ogawa et al., "Attenuation of ischemic myocardial injury and dysfunction by cardiac fbro-blast-derived factor(s)," Fukushima Journal of Medical Science, vol. 56, no. 1, pp. 1-16, 2010.
48. J. E. Cartledge, C. Kane, P. Dias et al., "Functional crosstalk between cardiac fbroblasts and adult cardiomyocytes by soluble mediators," Cardiovascular Research, vol. 105, no. 3, pp. 260-270, 2015.
49. C. Bang, S. Batkai, S. Dangwal et al., "Cardiac fbroblast-derived microRNA passenger strand-enriched exosomes mediate car-diomyocyte hypertrophy," The Journal of Clinical Investigation, vol. 124, no. 5, pp. 2136-2146, 2014.
50. L. Timmers, S. K. Lim, F. Arslan et al., "Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium," Stem Cell Research, vol. 1, no. 2, pp. 129-137, 2008.
51. F. Arslan, R. C. Lai, M. B. Smeets et al., "Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling afer myocardial ische-mia/reperfusion injury," Stem Cell Research, vol. 10, no. 3, pp. 301-312, 2013.
52. B. Yu, M. Gong, Z. He et al., "Enhanced mesenchymal stem cell survival induced by GATA-4 overexpression is partially mediated by regulation of the miR-15 family," International Journal of Biochemistry and Cell Biology, vol. 45, no. 12, pp. 2724-2735, 2013.
53. S. Sahoo, E. Klychko, T. Torne et al., "Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity," Circulation Research, vol. 109, no. 7, pp. 724-728, 2011.
54. E. Messina, L. De Angelis, G. Frati et al., "Isolation and expansion of adult cardiac stem cells from human and murine heart," Circulation Research, vol. 95, no. 9, pp. 911-921, 2004.
55. L. Barile, M. Gherghiceanu, L. M. Popescu, T. Moccetti, and G. Vassalli, "Human cardiospheres as a source of multipotent stem and progenitor cells," Stem Cells International, vol. 2013, Article ID 916837, 10 pages, 2013.
56. L. Barile, M. Gherghiceanu, L. M. Popescu, T. Moccetti, and G. Vassalli, "Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres," Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 354605, 10 pages, 2012.
57. L. Barile, V. Lionetti, E. Cervio et al., "Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function afer myocardial infarction," Cardiovascular Research, vol. 103, no. 4, pp. 530-541, 2014.
58. W. D. Gray, K. M. French, S. Ghosh-Choudhary et al., "Identif-cation of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology," Circulation Research, vol. 116, no. 2, pp. 255-263, 2015.
59. K. R. Vrijsen, J. P. G. Sluijter, M. W. L. Schuchardt et al., "Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells," Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1064-1070, 2010.
60. L. Chen, Y. Wang, Y. Pan et al., "Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury," Biochemical and Biophysical Research Communications, vol. 431, no. 3, pp. 566-571, 2013.
61. A. G.-E. Ibrahim, K. Cheng, and E. Marbán, "Exosomes as critical agents of cardiac regeneration triggered by cell therapy," Stem Cell Reports, vol. 2, no. 5, pp. 606-619, 2014.
62. J. I. Virag and C. E. Murry, "Myofbroblast and endothelial cell proliferation during murine myocardial infarct repair," American Journal of Pathology, vol. 163, no. 6, pp. 2433-2440, 2003.
63. S. Hu, M. Huang, Z. Li et al., "MicroRNA-210 as a novel therapy for treatment of ischemic heart disease," Circulation, vol. 122, no. 11, pp. S124-S131, 2010.
64. R. Katare, F. Riu, K. Mitchell et al., "Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132," Circulation Research, vol. 109, no. 8, pp. 894-906, 2011.
65. A. Osman, "MicroRNAs in health and disease-basic science and clinical applications," Clinical Laboratory, vol. 58, no. 5-6, pp. 393-402, 2012.
66. B. Zhang, Y. Yin, R. C. Lai, and S. K. Lim, "Immunotherapeutic potential of extracellular vesicles," Frontiers in Immunology, vol. 5, article 518, 2014.
67. I. S. Okoye, S. M. Coomes, V. S. Pelly et al., "MicroRNA-con-taining T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells," Immunity, vol. 41, no. 1, pp. 89-103, 2014.
68. N. Ismail, Y. Wang, D. Dakhlallah et al., "Macrophage micro-vesicles induce macrophage diferentiation and miR-223 transfer," Blood, vol. 121, no. 6, pp. 984-995, 2013.
69. Y. Pan, H. Liang, H. Liu et al., "Platelet-secreted MicroRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor," The Journal of Immunology, vol. 192, no. 1, pp. 437-446, 2014.
70. N. P. Bretz, J. Ridinger, A.-K. Rupp et al., "Body fuid exosomes promote secretion of infammatory cytokines in monocytic cells via Toll-Like receptor signaling," The Journal of Biological Chemistry, vol. 288, no. 51, pp. 36691-36702, 2013.
71. M. Hulsmans and P. Holvoet, "MicroRNA-containing micro-vesicles regulating infammation in association with atherosclerotic disease," Cardiovascular Research, vol. 100, no. 1, pp. 7-18, 2013.
72. G. Courties, T. Heidt, M. Sebas et al., "In vivo silencing of the transcription factor IRF5 reprograms the macrophage pheno-type and improves infarct healing," Journal of the American College of Cardiology, vol. 63, no. 15, pp. 1556-1566, 2014.
73. + T cells improve healing afer myocardial infarction by modulating monocyte/macrophage diferentiation," Circulation Research, vol. 115, no. 1, pp. 55-67, 2014.
74. T. Ben-Mordechai, D. Palevski, Y. Glucksam-Galnoy, I. Elron-Gross, R. Margalit, and J. Leor, "Targeting macrophage subsets for infarct repair," Journal of Cardiovascular Pharmacology and Terapeutics, vol. 20, no. 1, pp. 36-51, 2014.
75. J.-Y. Jang, J.-K. Lee, Y.-K. Jeon, and C.-W. Kim, "Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infltration and M2 polarization," BMC Cancer, vol. 13, article 421, 2013.
76. T. Yamaguchi, Y. Izumi, Y. Nakamura et al., "Repeated remote ischemic conditioning attenuates lef ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure afer myocardial infarction," International Journal of Cardiology, vol. 178, pp. 239-246, 2015.
77. J. Li, S. Rohailla, N. Gelber et al., "MicroRNA-144 is a circulating efector of remote ischemic preconditioning," Basic Research in Cardiology, vol. 109, no. 5, article 423, 2014.
78. K. M. Danielson and S. Das, "Extracellular vesicles in heart disease: excitement for the future ?" Exosomes and Microvesicles, vol. 2, no. 1, 2014.
79. J. Cosme, P. P. Liu, and A. O. Gramolini, "The cardiovascular exosome: current perspectives and potential," Proteomics, vol. 13, no. 10-11, pp. 1654-1659, 2013.
80. A. Agouni, R. Andriantsitohaina, and M. Martinez, "Micropar-ticles as biomarkers of vascular dysfunction in metabolic syndrome and its individual components," Current Vascular Pharmacology, vol. 12, no. 3, pp. 483-492, 2014.
81. S. Matsumoto, Y. Sakata, S. Suna et al., "Circulating p53-responsive MicroRNAs are predictive indicators of heart failure afer acute myocardial infarction," Circulation Research, vol. 113, no. 3, pp. 322-326, 2013.
82. R. Wang, N. Li, Y. Zhang, Y. Ran, and J. Pu, "Circulating micro RNAs are promising novel biomarkers of acute myocardial infarction," Internal Medicine, vol. 50, no. 17, pp. 1789-1795, 2011.
83. S. Viaud, C. Téry, S. Ploix et al., "Dendritic cell-derived exosomes for cancer immunotherapy: what's next?" Cancer Research, vol. 70, no. 4, pp. 1281-1285, 2010.
84. G. G. Romagnoli, B. B. Zelante, P. A. Toniolo, I. K. Migliori, and J. A. Barbuto, "Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets," Frontiers in Immunology, vol. 5, article 692, 2015.
85. S. Ailawadi, X. Wang, H. Gu, and G. C. Fan, "Pathologic function and therapeutic potential of exosomes in cardiovascular disease," Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1852, no. 1, pp. 1-11, 2015.
86. M. Mirotsou, A. Blusztanj, I. Tremmel et al., "Repeated doses of cardiosphere-derived cell extracellular vesicles are hypo-immu-nogenic," in Proceedings of the Abstracts from the 4th International Meeting of ISEV (ISEV '15), Journal of Extracellular Vesicles, Abstract Number O-8C-4, Washington, DC, USA, April 2015, http://www.journalofextracellularvesicles.net/index.php/jev/article/view/27783.
87. G. Maguire, "Stem cell therapy without the cells," Communicative and Integrative Biology, vol. 6, no. 6, Article ID e26631, 2013.
88. I. Chimenti, R. R. Smith, T.-S. Li et al., "Relative roles of direct regeneration versus paracrine efects of human cardiosphere-derived cells transplanted into infarcted mice," Circulation Research, vol. 106, no. 5, pp. 971-980, 2010.
89. K. M. Danielson and S. Das, "Extracellular vesicles in heart disease: excitement for the future?" Exosomes Microvesicles, vol. 2, no. 1, 2014.
90. D. M. Yellon and S. M. Davidson, "Exosomes: nanoparticles involved in cardioprotection?" Circulation Research, vol. 114, no. 2, pp. 325-332, 2014.
91. R. van der Meel, M. H. Fens, P. Vader, W. W. van Solinge, O. Eniola-Adefeso, and R. M. Schifelers, "Extracellular vesicles as drug delivery systems: lessons from the liposome feld," Journal of Controlled Release, vol. 195, pp. 72-85, 2014.
92. A. Aryani and B. Denecke, "Exosomes as a nanodelivery system: a key to the future of neuromedicine?" Molecular Neurobiology, 2014.
93. M. J. Haney, N. L. Klyachko, Y. Zhao et al., "Exosomes as drug delivery vehicles for Parkinson's disease therapy," Journal of Controlled Release, vol. 207, pp. 18-30, 2015.